AI assistant
Sending…
Vericel Corp — Director's Dealing 2011
Mar 28, 2011
31799_dirs_2011-03-28_ef68e396-2ff5-4b85-a5b9-3d7b452a054c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2011-03-24
Reporting Person: CRESSWELL RONALD M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-24 | Common Stock | P | 20000 | $2.19 | Acquired | 20000 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.20, inclusive. The reporting person undertakes to provide to Aastrom Biosciences, Inc., any security holder of Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
More from Vericel Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Annual Report
2026
Mar 19